Dr. Van Cutsem Discusses Regorafenib for the Treatment of Patients With Chemorefractory mCRC
Eric Van Cutsem, MD, PhD, discusses regorafenib for the treatment of patients with chemorefractory metastatic colorectal cancer (mCRC).
Chemotherapy Treatment in Gastric Cancer
Eric Van Cutsem, MD, PhD, discusses the challenges of using chemotherapy to treat patients with gastric cancer.